Editorial: US FDA Breast Implant Postapproval Studies-Long-term Outcomes in 99,993 Patients

被引:16
|
作者
Colwell, Amy S. [1 ]
Mehrara, Babak [2 ]
机构
[1] Harvard Med Sch, Massachusetts Gen Hosp, Div Plast & Reconstruct Surg, Boston, MA 02115 USA
[2] Mem Sloan Kettering Canc Ctr, Dept Surg, Div Plast & Reconstruct Surg, 1275 York Ave, New York, NY 10021 USA
关键词
WOMEN;
D O I
10.1097/SLA.0000000000003029
中图分类号
R61 [外科手术学];
学科分类号
摘要
引用
收藏
页码:39 / 40
页数:2
相关论文
共 8 条
  • [1] US FDA Breast Implant Postapproval Studies Long-term Outcomes in 99,993 Patients
    Coroneos, Christopher J.
    Selber, Jesse C.
    Offodile, Anaeze C.
    Butler, Charles E.
    Clemens, Mark W.
    ANNALS OF SURGERY, 2019, 269 (01) : 30 - 36
  • [2] Comment on "US FDA Breast Implant Post Approval Studies. Longterm Outcomes in 99,993 Patients''
    Nava, Maurizio Bruno
    Catanuto, Giuseppe
    Rocco, Nicola
    ANNALS OF SURGERY, 2019, 270 (02) : E63 - E63
  • [3] Analysis of Symmetry Stability Following Implant-Based Breast Reconstruction and Contralateral Management in 582 Patients with Long-Term Outcomes
    Barone, M.
    Cogliandro, A.
    Signoretti, M.
    Persichetti, P.
    AESTHETIC PLASTIC SURGERY, 2018, 42 (04) : 936 - 940
  • [4] Analysis of Symmetry Stability Following Implant-Based Breast Reconstruction and Contralateral Management in 582 Patients with Long-Term Outcomes
    M. Barone
    A. Cogliandro
    M. Signoretti
    P. Persichetti
    Aesthetic Plastic Surgery, 2018, 42 : 936 - 940
  • [5] Long-term outcomes in breast cancer patients undergoing immediate 2-stage expander/implant reconstruction and postmastectomy radiation
    Ho, Alice
    Cordeiro, Peter
    Disa, Joseph
    Mehrara, Babak
    Wright, Jean
    Van Zee, Kimberly J.
    Hudis, Clifford
    McLane, Amanda
    Chou, Joanne
    Zhang, Zhigang
    Powell, Simon
    McCormick, Beryl
    CANCER, 2012, 118 (09) : 2552 - 2559
  • [6] Clinical benefit of treatment with eribulin mesylate for metastatic triple-negative breast cancer: Long-term outcomes of patients treated in the US community oncology setting
    Mougalian, Sarah S.
    Copher, Ronda
    Kish, Jonathan K.
    McAllister, Lindsay
    Wang, Zhixiao
    Broscious, Mary
    Garofalo, David
    Radtchenko, Janna
    Feinberg, Bruce A.
    CANCER MEDICINE, 2018, 7 (09): : 4371 - 4378
  • [7] Long-term outcomes of high-risk HR-positive and HER2-negative early breast cancer patients from GEICAM adjuvant studies and El alamo IV registry
    Martin, Miguel
    Carrasco, Eva
    Rodriguez-Lescure, Alvaro
    Andres, Raquel
    Servitja, Sonia
    Anton, Antonio
    Ruiz-Borrego, Manuel
    Bermejo, Begona
    Guerrero, Angel
    Ramos, Manuel
    Santaballa, Ana
    Munoz, Montserrat
    Cruz, Josefina
    Lopez-Tarruella, Sara
    Chacon, Jose I. I.
    Alvarez, Isabel
    Martinez, Purificacion
    Miralles, Juan J.
    Polonio, Oscar
    Jara, Carlos
    Aguiar-Bujanda, David
    BREAST CANCER RESEARCH AND TREATMENT, 2023, 201 (02) : 151 - 159
  • [8] Long-term outcomes of high-risk HR-positive and HER2-negative early breast cancer patients from GEICAM adjuvant studies and El Álamo IV registry
    Miguel Martín
    Eva Carrasco
    Álvaro Rodríguez-Lescure
    Raquel Andrés
    Sonia Servitja
    Antonio Antón
    Manuel Ruiz-Borrego
    Begoña Bermejo
    Ángel Guerrero
    Manuel Ramos
    Ana Santaballa
    Montserrat Muñoz
    Josefina Cruz
    Sara Lopez-Tarruella
    Jose I. Chacón
    Isabel Álvarez
    Purificación Martínez
    Juan J. Miralles
    Óscar Polonio
    Carlos Jara
    David Aguiar-Bujanda
    Breast Cancer Research and Treatment, 2023, 201 : 151 - 159